Peripheral neuropathy Board decisions

The veteran is seeking service connection for acute and subacute peripheral neuropathy that he believes is related to herbicide exposure. The case has been remanded due to the need for a hearing before a veterans law judge.

The Board has determined that the evidence does not support an evaluation in excess of 30 percent for neuropathy of the tibial and peroneal nerves of the left lower extremity or a rating in excess of 20 percent for residuals of a left tibia fracture. The veteran's conditions are currently rated appropriately.

The Board denied the veteran's claims for service connection for multiple joint aches and pains, peripheral neuropathy, and colon disorder. The appeals were not granted.

The veteran's service-connected diabetic neuropathy of the upper extremities is currently evaluated as 10 percent disabling for each extremity. The medical evidence does not support a higher evaluation.

The veteran is in need of the regular aid and attendance of another person due to his service-connected disabilities, including PTSD, peripheral neuropathy, and diabetes.

The Board has remanded the case due to incomplete development of evidence, including obtaining medical records and conducting a VA examination. The veteran's service-connected right foot and ankle disability is being reviewed for an increased rating.

The veteran's service connection claims for various conditions are granted, including organic brain damage, peripheral neuropathy of the upper and lower extremities, multiple joint pain, tinnitus, chronic diarrhea, and headaches.

The Board denied the veteran's application to reopen his claim for service connection for sensorimotor polyneuropathy, bilateral lower extremities, Charcot-Marie-Tooth disease due to lack of new and material evidence.

The veteran's appeal is being remanded for additional development of his claims, including obtaining medical records and scheduling examinations.

The Board denied the appellant's claims for service connection for various conditions, including heart disease, hypertension, impotence, vision problems, prostate problems, and diabetic neuropathy of the lower extremities, all claimed as secondary to diabetes mellitus. The Board found no evidence linking these conditions to service or to Agent Orange exposure.

The Board has granted the veteran's claims for service connection and effective dates, with some issues receiving a 'granted' disposition.

The veteran's prostate cancer, peptic ulcer disease, bronchiectasis, and peripheral neuropathy were not incurred or aggravated during service. The Board found no evidence linking these conditions to service.

The veteran's diabetes mellitus II warrants a 40 percent disability rating for the period between November 20, 2001 and January 8, 2002. The veteran is not entitled to an increased rating for his diabetes mellitus prior to that date or on or after January 9, 2002.

The Board has granted service connection for bilateral neuropathy of the feet, residual to frostbite sustained during service in Korea.

The Board has granted service connection for erectile dysfunction as secondary to service-connected diabetes mellitus and peripheral neuropathy. The veteran's erectile dysfunction is due to or the result of his service-connected conditions.

The Board found that the effective date for the veteran's VA compensation benefits should be September 11, 2000, as this was the date he elected to receive such benefits. The earlier effective dates requested were denied.

The veteran seeks service connection for prostate cancer and peripheral neuropathy, both claimed as secondary to Agent Orange exposure. The case is being remanded due to the need for additional development regarding potential exposure to Agent Orange outside of Vietnam.

The Board has remanded the case due to the need for additional development, including obtaining VA and private medical records.

The veteran's service connection claims for bilateral pes planus, peripheral neuropathy of the upper and lower extremities, and a low back disability are all granted.

The Board granted increased evaluations for the veteran's pilonidal cyst and right ulnar neuropathy, both rated at 10 percent.